Header Logo

Connection

MITCHELL FREDERICK to Random Allocation

Back to Details
This is a "connection" page, showing publications MITCHELL FREDERICK has written about Random Allocation.
MITCHELL FREDERICK
Connection Strength
0.020
Random Allocation
  1. Targeted molecular therapy of head and neck squamous cell carcinoma with the tyrosine kinase inhibitor vandetanib in a mouse model. Head Neck. 2011 Mar; 33(3):349-58.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.